Fulgent Genetics, Inc. FLGT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 40.6%+2.7pp | 37.8%+1.7pp | 36.1%-23.2pp | 59.3%-19.0pp | |
| Operating margin | -28.2%-2.2pp | -26.1%+41.5pp | -67.6%-96.5pp | 28.8%-39.3pp | |
| Net margin | -18.8%-3.7pp | -15.1%+43.0pp | -58%-81.2pp | 23.2%-27.9pp | |
| EBITDA margin | -20.8%-3.5pp | -17.3%+41.3pp | -58.6%-92.7pp | 34.1%-35.1pp | |
| Free cash flow margin | -40.1%— | —— | 1.7%-36.3pp | 37.9%-13.9pp | |
| Returns | |||||
| Return on equity | -5.4%-1.6pp | -3.8%+10.2pp | -14%-25.8pp | 11.8%-46.9pp | |
| Return on assets | -5%-1.5pp | -3.5%+9.3pp | -12.8%-23.6pp | 10.8%-40.5pp | |
| Return on invested capital | -8.5%-1.5pp | -6.9%+10.4pp | -17.3%-29.8pp | 12.5%-55.0pp | |
| Efficiency | |||||
| Asset turnover | 0.3×0.0× | 0.2×0.0× | 0.2×-0.2× | 0.5×-0.5× | |
| Liquidity | |||||
| Current ratio | 6.5×+1.6× | 4.9×-2.1× | 7×-0.2× | 7.1×+1.3× | |
| Quick ratio | 6.5×+1.6× | 4.9×-2.1× | 7×-0.2× | 7.1×+1.3× | |
| Cash ratio | 0.6×-0.2× | 0.8×-0.6× | 1.3×+0.4× | 0.9×-0.7× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -1,214.6×— | —— | —— | 176.4×— | |
| Per Share | |||||
| Book value per share | $36.13-3.6% | $37.48-1.7% | $38.14-6.8% | $40.91+9.4% | |
| Valuation | |||||
| Market capitalization | $552.11M-7.1% | $564.94M-34.1% | $856.69M-4.8% | $900.1M-70.0% | |
| Enterprise value | $536.92M+0.7% | $516.12M-33.1% | $771.63M-8.0% | $838.28M-70.5% | |
| Price / sales | 1.7×-0.3× | 2×-1.0× | 3×+1.5× | 1.5×-1.6× | |
| Price / book | 0.5×0.0× | 0.5×-0.3× | 0.8×0.0× | 0.7×-1.9× | |
| EV / sales | 1.7×-0.1× | 1.8×-0.8× | 2.7×+1.3× | 1.4×-1.5× | |
| Free cash flow yield | -21.4%— | —— | 0.6%-25.5pp | 26.1%+8.9pp | |
| Earnings yield | -13.4%-6.5pp | -7.6%+12.0pp | -19.6%-35.5pp | 15.9%-1.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Fulgent Genetics, Inc.'s profit margins?
- Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
- Where do Fulgent Genetics, Inc.'s ratios come from?
- Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
